An independent report said Metroglass was left with “no viable alternatives”.
Vital wants shareholders to accept “without delay”.
Why are smaller firms better off as private companies?
There were 72 rises and 52 falls on the main board.
Intrepid increased its stake from from 60% to 100%.
Brent Robinson is pushing back.
The sale requires Australia’s Foreign Investment Review Board approval.
Why SkyCity may sell prime assets.
After flying into the NZX20 in June, a rival is rattling the utilities software firm.
Radius Healthcare joins Eroad on the rise on a trading day described as mildly positive.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details